Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging
- 6 July 2014
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 13 (8), 807-822
- https://doi.org/10.1016/s1474-4422(14)70101-2
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Molecular imaging of microglia/macrophages in the brainGlia, 2012
- Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptorNuclear Medicine and Biology, 2012
- 99mTc-labeled Rituximab for Imaging B Lymphocyte Infiltration in Inflammatory Autoimmune Disease PatientsMolecular Imaging & Biology, 2011
- Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlationsAnnals of Neurology, 2011
- Development of chemical exchange saturation transfer at 7TMagnetic Resonance in Medicine, 2011
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patientsAnnals of Neurology, 2010
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosisAnnals of Neurology, 2010
- In vivo mapping of brain myo-inositolNeuroImage, 2010
- Translocator Protein PET Imaging for Glial Activation in Multiple SclerosisJournal of Neuroimmune Pharmacology, 2010
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006